Inmune Bio, Inc. (INMB) KPIs and segments
INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.96+0.01 (+1.44%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Inmune Bio's business
Coming soon
This tab will track the numbers specific to Inmune Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?